FDA Inspection 1013086 — Sunrise Pharmaceutical, Inc.
The FDA completed an inspection of Sunrise Pharmaceutical, Inc. on Apr 6, 2017 in Rahway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 6, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rahway, NJ (United States)